Know Cancer

or
forgot password

MR Mammography: Randomized Controlled Trial to Study Efficiency of MR Mammography in Reducing the Number of Invasive Interventions in Nonpalpable Suspicious Breast Lesions. The MONET - Study


Phase 4
18 Years
75 Years
Open (Enrolling)
Female
Breast Neoplasms

Thank you

Trial Information

MR Mammography: Randomized Controlled Trial to Study Efficiency of MR Mammography in Reducing the Number of Invasive Interventions in Nonpalpable Suspicious Breast Lesions. The MONET - Study


Each year 7000 women present with nonpalpable suspicious breast lesions on mammography in
the Netherlands. In the usual care situation, these lesions are detected by mammography and
ultrasonography and pathologically characterized by analysis of large core needle biopsy
material. In case of malignancy, these lesions are surgically removed. First, a wire is
placed in the breast with the tip of the wire within 1 cm of the tumor and then the surgeon
follows the wire and removes the lesion. Unfortunately about 25% of women require more that
one surgical procedure to remove all tumorous tissue. This is caused by incorrect
presurgical diagnosis of the extent and invasiveness of the disease (multifocality,
multicentricity, lymph node involvement). We hypothesize that MR mammography will improve
presurgical diagnosis and differentiation of lesions and thereby decrease the number of
invasive surgical procedures (primary outcome) and number of invasive biopsies (secondary
outcome).


Inclusion Criteria:



- patients with a nonpalpable, mammographically suspicious breast lesion (BI-RADS 3, 4
or 5)

- referred for large core needle biopsy

- 18 to 75 years

Exclusion Criteria:

- previous breast surgery or radiation therapy of the breast less than 9 months
before MR mammography

- pregnant or lactating

- claustrophobia or adiposity ( > 130 kg)

- general contraindications for MRI

- unable to maintain prone position for one hour

- medically unstable patients

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

The absolute number of surgical procedures in women with nonpalpable malignancies will be compared between MRI group and control group.

Outcome Time Frame:

2010

Safety Issue:

No

Principal Investigator

Willem P Mali, MD PhD

Investigator Role:

Study Director

Investigator Affiliation:

UMC Utrecht

Authority:

Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)

Study ID:

UMC Utrecht

NCT ID:

NCT00302120

Start Date:

February 2006

Completion Date:

March 2010

Related Keywords:

  • Breast Neoplasms
  • Magnetic Resonance Imaging
  • Breast Neoplasms
  • Diagnostic Trial
  • Breast Neoplasms
  • Neoplasms

Name

Location